Electronic Component and Semiconductor: DexCom, Inc. (DXCM)

• Publication date: April 2012

This report is a source for data, analysis and actionable intelligence on the DexCom, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product description, function, te...

This report is a source for data, analysis and actionable intelligence on the DexCom, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Drug Delivery Technology Industry

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
DexCom, Inc. - Business Overview 4
Key Facts 4
DexCom, Inc. - Major Products and Services 5
DexCom, Inc. Pipeline Products by Equipment Type 6
DexCom, Inc. Pipeline Products by Development Stage 7
DexCom, Inc. Pipeline Products by Therapy Area 8
DexCom, Inc. Pipeline Products by Trial Phase 9
5th Generation Short-term Sensor 10
Product Status 10
Product Description 10
Product Patent Details 10
DexCom Long Term Sensor 15
Product Status 15
Product Description 15
DexCom Long Term Sensor Clinical Trial 15
Gen4 Sensor System 16
Product Status 16
Product Description 16
GlucoClear 16
Product Status 16
Product Description 16
Product Milestone 17
Product Patent Details 17
GlucoClear-2nd Generation 18
Product Status 18
Product Description 18
DexCom, Inc. - Top Competitors 19
DexCom, Inc. - Key Executives 20
DexCom, Inc. - Key Employee Biographies 21
DexCom, Inc. - Operations and Subsidiaries 22
Head Office 22
Recent Developments 23
March 03, 2011: DexCom Reports Total Sales s Of US$ 48.6m In 2010 23
November 04, 2010: DexCom Reports Net Loss Of US$ 13.40 Mln In Q3 2010 23
August 30, 2010: DexCom Announces Resignation Of Donald A. Lucas As Board Member 23
August 03, 2010: DexCom Reports Total Sales s Of US$ 11.78 Mln In Q2 2010 23
June 22, 2010: DexCom Appoints Steven Pacelli As COO And Jorge Valdes As Chief Technical Officer 24
May 05, 2010: DexCom Reports Total Sales s Of US$ 9.5 Mln In Q1 2010 24
March 26, 2010: DexCom Announces Retirement Of Chairman Donald Lucas From Board 25
March 09, 2010: DexCom Reports Total Sales s Of US$ 29.7 Mln In 2009 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26


List of Tables

DexCom, Inc., Major development 1
DexCom, Inc. Key Pipeline Products by Equipment Type 1
DexCom, Inc. Key Pipeline Products by Therapy Area 1
DexCom, Inc. Key Pipeline Products by Development Stage 1
DexCom, Inc. Key Pipeline Products by Trial Phase 1
DexCom, Inc., Major development 4
DexCom, Inc., Major Products and Services 5
DexCom, Inc. Number of Pipeline Products by Equipment Type 6
DexCom, Inc. Pipeline Products by Equipment Type 6
DexCom, Inc. Number of Pipeline Products by Development Stage 7
DexCom, Inc. Pipeline Products by Development Stage 7
DexCom, Inc. Number of Pipeline Products by Therapy Area 8
DexCom, Inc. Pipeline Products by Therapy Area 8
DexCom, Inc. Number of Pipeline Products by Trial Phase 9
DexCom, Inc. Pipeline Products by Trial Phase 9
5th Generation Short-term Sensor - Product Status 10
5th Generation Short-term Sensor - Product Description 10
5th Generation Short-term Sensor - Patent Details 10
DexCom Long Term Sensor - Product Status 15
DexCom Long Term Sensor - Product Description 15
DexCom Long Term Sensor - Improved Glucose Excursions Using an Implantable Real-time Continuous Glucose Sensor in Adults with Type 1 Diabetes 15
Gen4 Sensor System - Product Status 16
Gen4 Sensor System - Product Description 16
GlucoClear - Product Status 16
GlucoClear - Product Description 16
GlucoClear - Product Milestone 17
GlucoClear - Patent Details 17
GlucoClear-2nd Generation - Product Status 18
GlucoClear-2nd Generation - Product Description 18
DexCom, Inc., Key Executives 20
DexCom, Inc., Key Employee Biographies 21


List of Figures

DexCom, Inc. Pipeline Products by Equipment Type 6
DexCom, Inc. Pipeline Products by Development Stage 7
DexCom, Inc. Pipeline Products by Therapy Area 8
DexCom, Inc. Pipeline Products by Trial Phase 9

Companies mentioned MediSense Inc.
TheraSense, Inc.
Bayer Corporation
Becton, Dickinson and Firms
Disetronic Medical Systems AG
LifeScan, Inc.